17 déc. 2005 - EBCTCG RT

Description:

Message: Survival benefit is a result of the local-regional control benefit.
1 / 4 Ratio: One death from breast cancer avoided for every four LR recurrences avoided.

Anthracycline-based chemotherapy and hormone therapy in the ER-positive patients reduced mortality among premenopausal (38%) and postmenopausal (20%); 5-year duration more effective than 1-2 year course